Compare Mutual Funds
Risk
Very High
-
Rating
2.0
-
Min SIP Amount
₹100
-
Expense Ratio
2.28
-
NAV
₹40.08
-
Fund Started
20 Jun 2019
-
Fund Size
₹1010.54 Cr
-
Exit Load
Exit load of 1% if redeemed within 30 days.
-
1 Year
15.47%
-
3 Year
21.97%
-
5 Year
13.47%
-
Equity
97.85%
-
Cash
2.15%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.09% |
Apollo Hospitals Enterprise Ltd. | 7.30% |
JB Chemicals & Pharmaceuticals Ltd. | 4.71% |
Torrent Pharmaceuticals Ltd. | 4.68% |
Aurobindo Pharma Ltd. | 4.55% |
Ajanta Pharma Ltd. | 4.38% |
Mankind Pharma Ltd. | 3.92% |
Lupin Ltd. | 3.74% |
Sai Life Sciences Ltd. | 3.50% |
Abbott India Ltd. | 3.26% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
-
Launch Date
20 Jun 2019
-
